San Francisco Bay Area biotech stories.
Thursday, February 24, 2011
Amyris inks perfume deal with Switzerland's Givaudan
Amyris Inc. made an agreement with Swiss company Givaudan to develop an ingredient for perfumes.
Givaudan is based in Vernier, Switzerland. It will use Amyris’ product “Biofene” (farnesene) for perfume products that could be created as early as 2012.
Emeryville-based Amyris (NASDAQ: AMRS) didn’t give financial details of this deal.
Share to Twitter
Share to Facebook
Share to Pinterest
Post a Comment
Post Comments (Atom)